Copyright
©The Author(s) 2019.
World J Clin Cases. Jul 26, 2019; 7(14): 1825-1836
Published online Jul 26, 2019. doi: 10.12998/wjcc.v7.i14.1825
Published online Jul 26, 2019. doi: 10.12998/wjcc.v7.i14.1825
Table 4 Detailed description of costs of outpatient parenteral antibiotic therapy and inpatient parenteral antibiotic therapy depending on available information
ID | First author | Ref. | Cost IPAT | Cost OPAT | Cost-difference | Comment |
1 | Al Alawi1 | [8] | €43152.41 / €50343.67 €143.37/d2 | €17261.45 €57.35/d2 | €25890.96 €86.02/d2 | 301 bed days were saved by OPAT. Exact cost reduction not clear in text |
2 | Antoniskis | [9] | US $234.22/d US $10022.23 /pat | US $69.35/d US $6357.52/pat | US $229.70/d US $3664.71/pat | Historical data/prices from 1977/78. Average day costs calculated |
3 | Bernard | [10] | US $710/d US $2233945 | US $129/d US $360060 | US $581/d US $1873885 | 2.147 patient-days of 39 patients |
4 | Chapman | [11] | £372.53/d £1502769 | £151.79/d £612306 | £220.74/d £890,463 | Calculation based on 4034 bed-days |
5 | Connors1 | [12] | CAN $1720.70 / d CAN $717530 €1063451.21 | CAN $1094/d CAN $120096 €177994.28 | CAN $288/d CAN $597434 €884919.24 | 110 patients with 417 bed-days. Average: 3.8 d with CAN $1094 / case |
6 | Gonzales | [13] | €4357/pat €518.70/d | €2350/pat €98.30/d | €420.40/d | Very detailed calculation. Methods presented. IPAT for an average of 8.4 days. OPAT included IPAT for readmission within 30 d |
7 | Gray | [14] | £192635 £662/patient | Simulation of cost analysis based on potentially saved bed days. Calculation include OPAT as well as other treatment changes. 18/429 patients in the calculation would have been eligible for OPAT | ||
8 | Grizzard | [15] | US $159.54/d US $101314 | US $112.68/d US $29763 | US $112.68/d US $71551 | Historical data (1988). Cost-Charge Ratio. Additional Homecare-treatment (OPHAT) of center based OPAT and IPAT differentiated. 635 bed days |
9 | Harrison | [16] | £264 / d £84480 | £109.59 / d £35070 | £154.41 / d £49,410 | Simplified calculation. 320 bed days |
10 | Heintz | [17] | US $424080 US $658.50/visit | Simplified calculation with relevant limitations. 228 bed days were saved by OPAT | ||
11 | Kieran | [18] | €342862 | €167.60/d €558912 | €-216.050 | Prospective study on 60 cases. 1289 bed days saved. Community nurses included in OPAT calculation |
12 | Lacroix | [19] | €1125/d €335250 | €228/d €67943 | €897/d €14850/pat €267307 | Simulated cost analysis. 298 bed days saved |
13 | Malone | [20] | US $829/d US $1143.957 | US $278848 | US $14661/pat US $864997 | IPAT costs based on Council of Australian Governments. 1,569 bed days saved |
14 | Nathwani | [21] | £300 / d £11400 / pat £627000 | £1,749.15/pat £96,203.25 | £9650.85/pat £530796.75 | Three groups: IPAT, OPAT (Teicoplanin) and outpatient oral therapy (Linezolid). Oral group not included |
15 | Nguyen | [22] | US $1180/d US $556960 | US $385/d US $181720 | US $795/d US $375240 | 472 OPAT visits |
16 | Ruh | [23] | US $7540135.35 | US $607583.32 | US $6932552.03 | Complex cost calculation with multiple factors |
17 | Seaton | [24] | £13019.57/pat £455685 | £6,532.89/pat £228651 | £6,487/pat £227034 | Three groups: IPAT, OPAT (Teicoplanin) and outpatient oral therapy (Linezolid). Oral group not included. Calculation based on 37 cases |
18 | Sims | [25] | £250/d £14500/pat | £24/d 1392/pat | £24/d £13108/pat | For two weeks OPAT cost reduction of 2108 £/Pat |
19 | Theocharis | [26] | €167.50-195.50/d | €164/d €637/pat | Re-admission rates (14.2%) and costs not included in OPAT calculation | |
20 | Wai | [27] | €20728/pat €2901983 | €2774/pat €388402 | €17954/pat €2513580 | Very detailed cost analysis for IPAT and OPAT. Perspectives of payer and hospitals were presented |
21 | Yong | [28] | US $457/d US $12403/pat | US $278/d US $12736/pat | Includes calculation for opportunity-costs |
- Citation: Boese CK, Lechler P, Frink M, Hackl M, Eysel P, Ries C. Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review. World J Clin Cases 2019; 7(14): 1825-1836
- URL: https://www.wjgnet.com/2307-8960/full/v7/i14/1825.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i14.1825